Sticking with their acquisition plan, BioMarin has purchased a number of strategic companies that have greatly expanded their pipeline and accelerated growth. The company purchased LEAD Therapeutics ...
The Orphan Drug pipeline of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has been growing so rapidly that the company has been the object of many takeover rumors since 2006 when it was believed that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback